U.S. Medtech Venture Financing Totaled Nearly $770 Million in December 2019

Total medical devices industry venture financing deals in December 2019 worth $769.28 million were announced in the United States, according to GlobalData’s deals database.
 
The value marked an increase of 16.1 percent over the previous month and a rise of 38.4 percent when compared with the last 12-month average of $555.87 million.
 
The US held a 64.6 percent share of the global medical devices industry venture financing deal value that totalled $1.19 billion in December 2019.
 
In terms of deal activity, the United States recorded 50 deals during December 2019, marking a decrease of 9.1 percent over the previous month and a drop of 18.03 percent over the 12-month average.
 
The top five medical devices industry venture financing deals accounted for 51.4 percent of the overall value during December 2019.
 
The combined value of the top five medical devices venture financing deals stood at $395.6 million, against the overall value of $769.28 million recorded for the month.
 
The top five medical devices industry deals of December 2019 tracked by GlobalData were:

• Foresite Capital Management, JS Capital Management, Merieux Developpement, MLS Capital Fund II, NanoDimension Management, Oak HC/FT Partners, Paladin Capital Group and Venrock’s $125 million venture financing of Inscripta.
• The $85 million venture financing of Imperative Care by 3H Health Investment, Ally Bridge Group, Ascension Ventures, Bain Capital Life Sciences, Delos Capital, Incept and Rock Springs Capital Management.
• ArrowMark Partners, Broadfin Capital, CVF, Essex Woodlands Management, General Atlantic, JMR Capital, Meritech Capital Partners, NeoMed Management, Orbimed Advisors, Perceptive Advisors, Redmile Group, SEB Private Equity and Security Pacific Finance’s $85 million venture financing of Sonendo.
• The $55 million venture financing of ArcherDx by ArrowMark Partners, Boulder Ventures, Driehaus Capital Management, Longwood Fund Management, PBM Capital Group, Perceptive Advisors, Redmile Group, Sands Capital Management and Soleus Capital Management.
• Barco, Drug Discovery Gateway InvestmentPartnership, IPF Management, Mitsubishi, Plug and Play Ventures, Relyens, Whiz Partners andInc.’s venture financing of Caresyntax for $45.6 million.